SCHEMBL1043810

SCHEMBL1043810

CCOC(=O)C(C(=O)OCC)c1cccc(C(F)(F)F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 1/20 0.49
▸ PNMT P11086 1/20 0.49
▸ THRB P10828 1/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ MMP8 P22894 1/20 0.47
▸ MAPT P10636 2/20 0.46
▸ GAA P10253 2/20 0.46
▸ CHRM2 P08172 1/20 0.46
▸ CHRM4 P08173 1/20 0.46
▸ CHRM3 P20309 1/20 0.46
▸ ALOX12 P18054 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ EPHX1 P07099 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30836057 1.00 CES2 (0.49) CES2PNMTTHRBALDH1A1SMN1; SMN2
SCHEMBL11432112 0.93 EPHX1 (0.52) CES2PNMTTHRBALDH1A1SMN1; SMN2
SCHEMBL4750069 0.93 CES2 (0.46) CES2PNMTTHRBALDH1A1SMN1; SMN2
SCHEMBL10727655 0.92 ALDH1A1 (0.43) CES2PNMTTHRBALDH1A1SMN1; SMN2
SCHEMBL10583768 0.90 CES2 (0.44) CES2PNMTTHRBALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL10386368 0.89 EPHX1 (0.44) CES2PNMTTHRBALDH1A1SMN1; SMN2
SCHEMBL30836086 0.88 CES2 (0.47) CES2PNMTALDH1A1SMN1; SMN2MEN1
SCHEMBL28452948 0.88 CES2 (0.47) CES2PNMTALDH1A1SMN1; SMN2MEN1
SCHEMBL15018577 0.88 CES2 (0.51) CES2PNMTALDH1A1SMN1; SMN2MEN1
SCHEMBL30368489 0.88 CES2 (0.51) CES2PNMTALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111592539-B Preparation method of trifluoro-benzene pyrimidine 江西农业大学 2022-11-15 — — CN claimed
CN-111592539-A Preparation method of trifluoro-benzene pyrimidine 江西农业大学 2020-08-28 — — CN claimed
CN-111592539-B Preparation method of trifluoro-benzene pyrimidine 江西农业大学 2022-11-15 — — CN disclosed
CN-109651365-B 3-methylpyrido [1,2-a ] pyrimidone derivative containing 1- ((4-substituted benzyl) oxy) and application thereof 贵州大学 2021-11-16 — — CN disclosed
CN-112574194-A Synthesis and application of pyrimidinium salt compound 东莞市东阳光农药研发有限公司 2021-03-30 — — CN disclosed
CN-110317200-B Pyrimidinium compounds and uses thereof 东莞市东阳光农药研发有限公司 2020-09-11 — — CN disclosed
CN-111592539-A Preparation method of trifluoro-benzene pyrimidine 江西农业大学 2020-08-28 — — CN disclosed
CN-107266275-B Compound containing monofluoromethyl, preparation method and application thereof 中国科学院上海有机化学研究所 2020-07-07 — — CN disclosed
CN-107531700-B Mesoionic compounds 日本化药株式会社 2020-03-03 — — CN disclosed
US-20200017490-A1 Novel Mesoionic Insecticidal Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2020-01-16 — — US disclosed
EP-3287457-B1 MESOIONIC COMPOUND NIPPON KAYAKU KK (JP) 2019-09-18 — — EP disclosed
US-7115784-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-10-03 — — US disclosed
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2005-09-29 — — US disclosed
US-6867298-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2005-03-15 — — US disclosed
CN-1518534-A Copper-catalyzed carbon-heteroatom and carbon-carbon bond formation 麻省理工学院 2004-08-04 — — CN disclosed
US-6759554-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2004-07-06 — — US disclosed
EP-1390340-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-02-25 — — EP disclosed
US-20040019216-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-01-29 — — US disclosed
US-20030065187-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-04-03 — — US disclosed
WO-2002085838-A1 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2002-10-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215794-A1 Copper-catalyzed formation of carbon heteroatom and carbon-carbon bonds CBR3, ADH5, IDH1 CES2 230/4885PNMT 257/4885THRB 3763/4885
US-20030065187-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds ADH5, CBR3, ALDH3A1 CES2 190/4885PNMT 402/4885THRB 3667/4885
US-20040019216-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds ADH5, CBR3, ALDH3A1 CES2 190/4885PNMT 402/4885THRB 3667/4885
US-20200017490-A1 Novel Mesoionic Insecticidal Compound DDT, ACHE, ME3 CES2 884/4885PNMT 576/4885THRB 1942/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback